导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 1.45% | 337/924 |
| 近一周 | 0.04% | 198/971 |
| 近一月 | 0.08% | 124/958 |
| 近一季 | 0.38% | 346/954 |
| 近半年 | 0.68% | 321/936 |
| 近一年 | 1.61% | 343/921 |
| 近两年 | 4.62% | 469/820 |
| 近三年 | 7.87% | 432/692 |
| 成立以来 | 20.54% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
0.28% 214/917 |
0.57% 625/957 |
0.24% 326/973 |
- - |
| 2024 | 2.84% 496/908 |
0.88% 431/846 |
0.70% 633/862 |
0.25% 435/878 |
0.97% 429/908 |
| 2023 | 3.11% 444/832 |
0.95% 348/751 |
0.81% 549/771 |
0.52% 446/802 |
0.78% 444/832 |
| 2022 | 2.11% 268/729 |
0.68% 216/525 |
0.76% 338/610 |
0.65% 389/652 |
- 359/729 |
| 2021 | 3.41% 157/489 |
0.93% 70/330 |
0.90% 123/361 |
0.78% 207/413 |
0.75% 233/489 |
| 2020 | 2.99% 66/351 |
1.27% 115/251 |
0.48% 44/292 |
0.49% 97/302 |
0.72% 141/329 |
| 2019 | - - |
- - |
0.76% 549/1825 |
0.89% 103/207 |
0.82% 97/237 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 易方达标普生物科技美元汇A | 0.2432 | 29.46% |
| 易方达标普生物科技美元汇C | 0.2399 | 28.01% |
| 汇安行业龙头混合A | 2.4323 | 22.37% |
| 华商致远回报混合A | 1.6762 | 21.58% |
| 广发生物科技指数美元(QDII)C | 0.2047 | 18.46% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)美元现汇 | 1.3424 | 17.84% |
| 华夏上证科创板半导体材料设备主题ETF联接C | 1.2373 | 17.83% |
| 宝盈国家安全沪港深股票C | 2.1469 | 17.42% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)人民币A | 1.3726 | 17.14% |
| 广发上海金ETF | 9.7032 | 16.81% |
| 永赢迅利中高等级短债A VS. () |